Author | Anthony W. Tolcher, MD | OncLive

Author | Anthony W. Tolcher, MD


Dr. Tolcher on Utomilumab Plus Pembrolizumab in Advanced Solid Tumors

July 25, 2016


Anthony W. Tolcher, MD, director of clinical research at South Texas Accelerated Research Therapeutics San Antonio, discusses a phase Ib study examining the combination of the 4-1BB agonist utomilumab (PF-05082566) and pembrolizumab (Keytruda) as a treatment for patients with advanced solid tumors.